<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Unclassifiable <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with features intermediate between diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is a new category of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> appearing in the new World Health Organization Classification of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> of Haematopoietic and Lymphoid Tissues </plain></SENT>
<SENT sid="1" pm="."><plain>This <z:hpo ids='HP_0002665'>lymphoma</z:hpo> usually shows MYC rearrangements with non-IGH genes in the setting of a complex karyotype possibly involving BCL2 and, less frequently, BCL6 rearrangements </plain></SENT>
<SENT sid="2" pm="."><plain>According to the presence of two or three rearrangements, these <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are called double-hit <z:hpo ids='HP_0002665'>lymphomas</z:hpo> or triple-hit <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (THL), respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report two cases of THL with MYC, BCL2, and BCL6 rearrangements and t(3;8)(q27;q24) diagnosed in one center in the last two years </plain></SENT>
</text></document>